Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Formula | C26H45NO6S |
|||
Molecular Weight | 499.70 | CAS No. | 516-35-8 | |
Solubility (25°C)* | In vitro | DMSO | 99 mg/mL (198.11 mM) | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
Description | Taurochenodeoxycholic acid (Taurochenodeoxycholate, TCDCA, Chenodeoxycholyltaurine), a bile acid formed in the liver of most species, is used as a cholagogue and choleretic. |
---|---|
In vitro | Taurochenodeoxycholic acid (TUDCA) induces dissociation of CD34+ HSCs from stromal cells by decreasing adhesion molecule expression. It induces bone marrow stem cell mobilization and differentiation into endothelial progenitor cells (EPCs) and enhances EPC proliferation, invasion, and tube formation via Akt and ERK activation[1]. TCDCA induces the apoptosis process through the activation of caspase cascade in macrophages, and this process may be involved in PKC/JNK signaling pathway[2]. |
In vivo | TUDCA has neuroprotective effects in neuronal cultures and positive effects on ischemia reperfusion in animal models, reducing infarct area and inflammation via attenuation of endoplasmic reticulum (ER) stress. TUDCA is incorporated into target cells via organic anion transporter (OATP) 2, OATP8, and the Na+‐taurocholate cotransporting polypeptide (NTCP). TUDCA inhibits neointimal hyperplasia by promoting apoptosis of smooth muscle cells via induction of MAP kinase phosphatase‐1 (MKP‐1) expression. In addition, TUDCA protects the hepatocytes and restores glucose homeostasis by reducing ER stress. TUDCA enhances neovascularization in vivo[1]. TCDCA in dosages of 0.05 and 0.1g/kg can extremely significantly decrease the pulmonary coefficient in the model mice. TCDCA in a dosage of 0.2g/kg significantly decreases the pulmonary coefficient in the model mice (P<0.05); TCDCA in dosages of 0.05 and 0.1g/kg significantly reduce the pathological damages on their lungs; TCDCA can extremely significantly decrease the expression levels of TNF-α and TIMP-2 in pulmonary tissues in the pulmonary fibrosis mice (P>0.01), the expression level of MMP-9 extremely significantly increased (P>0.01), while it has no significant effects on MMP2. Thus, TCDCA has antagonistic actions on pulmonary fibrosis in mice[3]. |
Cell Assay:[1] |
|
---|---|
Animal Study:[1] |
|
|
Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma [ Nat Commun, 2021, 12(1):6479] | PubMed: 34759281 |
Antibiotic-modulated microbiome suppresses lethal inflammation and prolongs lifespan in Treg-deficient mice. [ Microbiome, 2019, 7(1):145] | PubMed: 31699146 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.